PTC Therapeutics, Inc. - Laporan Laba Rugi (TTM)

PTC Therapeutics, Inc.
DE ˙ DB ˙ US69366J2006
€ 49.20 ↑2.00 (4.24%)
2025-09-05
BAHAGING PRESYO
Laporan Laba Rugi (TTM)

Laporan Laba Rugi PTC Therapeutics, Inc. menunjukkan perubahan pendapatan dan pengeluaran selama periode waktu tertentu. Data Laporan Laba Rugi meliputi Penjualan dan Pendapatan, Laba Kotor, Penelitian dan Pengembangan (R&D), Beban Penjualan, Umum dan Administrasi (SG&A), Laba Operasi, Beban Pajak Penghasilan, Beban Bunga, Pendapatan Non-Operasi, Laba per Saham (EPS), dan Saham yang Beredar.

Semua angka adalah kelipatan 1,000,000 kecuali unit per saham.

2020
09-30
2020
12-31
2021
03-31
2021
06-30
2021
09-30
2021
12-31
2022
03-31
2022
06-30
2022
09-30
2022
12-31
2023
03-31
2023
06-30
2023
09-30
2023
12-31
2024
03-31
2024
06-30
2024
09-30
2024
12-31
2025
03-31
2025
06-30
Revenue 358 381 430 472 492 539 569 618 697 699 770 819 798 938 928 900 901 807 1,773 1,765
Change (%) 6.25 13.05 9.63 4.31 9.42 5.72 8.58 12.68 0.31 10.25 6.27 -2.51 17.50 -1.09 -2.92 0.02 -10.42 119.73 -0.44
% of Revenue 100.00 100.00 100.00 100.00 100.00 100.00 100.00 100.00 100.00 100.00 100.00 100.00 100.00 100.00 100.00 100.00 100.00 100.00 100.00 100.00
Cost Of Sales 397 443 492 477 516 573 577 625 684 696 758 797 781 732 654 603 601 592 583 560
Change (%) 11.45 11.16 -3.09 8.15 11.03 0.74 8.33 9.45 1.72 8.82 5.17 -1.96 -6.29 -10.71 -7.79 -0.24 -1.57 -1.53 -4.00
% of Revenue 110.92 116.34 114.39 101.13 104.85 106.39 101.38 101.15 98.25 99.62 98.33 97.32 97.87 78.06 70.47 66.94 66.76 73.36 32.88 31.70
Gross Operating Profit -39 -62 -62 -5 -24 -34 -8 -7 12 3 13 22 17 206 274 298 299 215 1,190 1,205
Change (%) 59.04 -0.41 -91.41 348.29 44.32 -77.12 -9.92 -272.30 -78.50 389.95 70.66 -22.55 1,109.50 33.11 8.69 0.56 -28.21 453.70 1.30
% of Revenue -10.92 -16.34 -14.39 -1.13 -4.85 -6.39 -1.38 -1.15 1.75 0.38 1.67 2.68 2.13 21.94 29.53 33.06 33.24 26.64 67.12 68.30
SG&A 233 244 247 263 274 286 298 309 320 326 340 348 349 333 319 300 293 301 309 324
Change (%) 4.83 1.18 6.15 4.35 4.30 4.26 3.70 3.52 1.93 4.18 2.52 0.22 -4.71 -4.10 -5.94 -2.48 2.87 2.56 5.11
% of Revenue 65.08 64.20 57.46 55.64 55.66 53.06 52.33 49.97 45.91 46.65 44.08 42.53 43.72 35.46 34.38 33.31 32.48 37.30 17.41 18.38
R&D
Change (%)
% of Revenue
OpEx 665 724 780 784 839 914 942 1,015 1,101 1,139 1,230 1,299 1,311 1,287 1,207 1,093 1,028 954 904 898
Change (%) 8.93 7.68 0.52 7.02 8.88 3.13 7.71 8.53 3.39 7.99 5.60 0.99 -1.84 -6.21 -9.47 -5.90 -7.28 -5.15 -0.70
% of Revenue 185.56 190.23 181.20 166.14 170.46 169.62 165.47 164.14 158.10 162.95 159.61 158.61 164.29 137.26 130.16 121.37 114.18 118.19 51.02 50.89
Operating Income -307 -344 -350 -312 -347 -375 -373 -397 -405 -440 -459 -480 -513 -349 -280 -192 -128 -147 868 867
Change (%) 12.06 1.73 -10.70 11.12 8.11 -0.58 6.38 2.07 8.69 4.40 4.48 6.95 -31.91 -19.94 -31.20 -33.62 14.87 -691.70 -0.17
% of Revenue -85.56 -90.23 -81.20 -66.14 -70.46 -69.62 -65.47 -64.14 -58.10 -62.95 -59.61 -58.61 -64.29 -37.26 -30.16 -21.37 -14.18 -18.19 48.98 49.11
Interest Expense -40 -56 -71 -88 -88 -86 -90 -89 -87 -91 -99 -106 -115 -129 -153 -178 -171 -170 -170 -167
Change (%) 39.30 25.23 24.06 0.53 -2.26 4.13 -0.54 -2.83 4.96 8.71 7.12 8.39 12.36 18.97 16.22 -4.03 -0.36 -0.26 -1.55
% of Revenue -11.29 -14.80 -16.39 -18.55 -17.88 -15.97 -15.73 -14.41 -12.43 -13.00 -12.82 -12.93 -14.37 -13.74 -16.53 -19.79 -18.99 -21.12 -9.59 -9.48
Net Income -441 -438 -454 -391 -455 -524 -522 -556 -531 -559 -571 -618 -642 -627 -579 -480 -453 -363 595 629
Change (%) -0.75 3.64 -13.89 16.35 15.15 -0.37 6.46 -4.37 5.20 2.19 8.19 3.83 -2.35 -7.56 -17.21 -5.49 -19.84 -263.74 5.77
% of Revenue -123.20 -115.07 -105.50 -82.87 -92.43 -97.27 -91.68 -89.89 -76.28 -80.00 -74.15 -75.49 -80.40 -66.81 -62.45 -53.25 -50.32 -45.03 33.55 35.65

Source: Capital IQ

Other Listings
US:PTCT US$ 57.26
Fintel data has been cited in the following publications:
Daily Mail Fox Business Business Insider Wall Street Journal The Washington Post Bloomberg Financial Times Globe and Mail
NASDAQ.com Reuters The Guardian Associated Press FactCheck.org Snopes Politifact
Federal Register The Intercept Forbes Fortune Magazine TheStreet Time Magazine Canadian Broadcasting Corporation International Business Times
Cambridge University Press Investopedia MarketWatch NY Daily News Entrepreneur Newsweek Barron's El Economista